Home
Journals
Archaeology International
Architecture_MPS
Europe and the World: A law review
Film Education Journal
History Education Research Journal
International Journal of Development Education and Global Learning
International Journal of Social Pedagogy
Jewish Historical Studies: A Journal of English-Speaking Jewry
Journal of Bentham Studies
London Review of Education
Radical Americas
Research for All
The Journal of the Sylvia Townsend Warner Society
The London Journal of Canadian Studies
About
About UCL Press
Who we are
Contact us
My ScienceOpen
Sign in
Register
Dashboard
Search
Home
Journals
Archaeology International
Architecture_MPS
Europe and the World: A law review
Film Education Journal
History Education Research Journal
International Journal of Development Education and Global Learning
International Journal of Social Pedagogy
Jewish Historical Studies: A Journal of English-Speaking Jewry
Journal of Bentham Studies
London Review of Education
Radical Americas
Research for All
The Journal of the Sylvia Townsend Warner Society
The London Journal of Canadian Studies
About
About UCL Press
Who we are
Contact us
My ScienceOpen
Sign in
Register
Dashboard
Search
73
views
0
references
Top references
cited by
3
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,766
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Developing Drug Products in an Aging Society
other
Editor(s):
Sven Stegemann
Publication date
(Print):
2016
Publisher:
Springer International Publishing
Read this book at
Publisher
Buy book
Review
Review book
Invite someone to review
Bookmark
Cite as...
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Developing Data Infrastructures
Author and book information
Book
ISBN (Print):
978-3-319-43097-3
ISBN (Electronic):
978-3-319-43099-7
Publication date (Print):
2016
DOI:
10.1007/978-3-319-43099-7
SO-VID:
01d743db-c9f8-40f8-85eb-5515e29b31be
License:
http://www.springer.com/tdm
History
Data availability:
Comments
Comment on this book
Sign in to comment
Book chapters
pp. E1
Erratum to: European Medicines Agency (EMA): Regulatory Perspectives on Geriatric Medicines
pp. 3
Healthcare Provisions in an Aging Society: U.S. Perspective
pp. 23
Healthcare Provision in an Aging Society—The European Perspective
pp. 45
Healthcare Provisions in the Aging Society: Japanese Perspectives
pp. 61
Old, Very Old and Frail
pp. 67
Age and the Process of Aging
pp. 87
Comprehensive Geriatric Assessment
pp. 103
Patients’ Clinical Characteristics, Disease Experience, and Perception
pp. 117
Ethical Considerations in Performing Clinical Trials in and for Older People
pp. 129
Patient Reported Outcomes in Clinical Trials and Practice with Older Patients
pp. 139
Pharmacokinetic and Pharmacodynamic Considerations in Elderly Population
pp. 153
The Expectation to Treatment Model: A Framework for Adherence and Effectiveness
pp. 171
Pharmacoepidemiology and Pharmacovigilance for Safety and Efficacy in Older People
pp. 191
Defining Patient Centric Drug Product Design and Its Impact on Improving Safety and Effectiveness
pp. 217
Dosing Considerations in Older Adults
pp. 225
Oral Drug Product Use in the Elderly Patient Population
pp. 247
Drug Product Development for Older Adults—Multiparticulate Formulations
pp. 279
Considerations for Topical and Transdermal Drug Delivery in Older Adults
pp. 291
Parenteral Drug Delivery for Older Patients
pp. 331
Inhalation and Nasal Formulations
pp. 383
Ophthalmic Drug Development and the Elderly
pp. 403
Developing Drug Administration Devices for Geriatric Use
pp. 447
Manufacturing Platforms for Patient-Centric Drug Products
pp. 485
Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products
pp. 519
Prescribing to Older Adults
pp. 549
Multimorbidity and Polypharmacy
pp. 563
Vaccination in Older Adults
pp. 577
Medication Reviews in Older Adults
pp. 589
The Personalization of Drug Therapy for Elderly Patients
pp. 613
Importance of Clinical Nutrition in Therapy to Older Adults
pp. 629
Managing Drug Therapy of Older Patients in Primary and Secondary Care
pp. 659
Medication Adherence and Monitoring
pp. 675
Medication Compounding in the Provision of Drug Therapy
pp. 683
Geriatric Pharmacotherapy: Optimisation Through Integrated Approach in the Hospital Setting
pp. 701
European Medicines Agency (EMA): Regulatory Perspectives on Geriatric Medicines
pp. 719
Views on the Therapeutic Needs of Older Adults
pp. 737
Future Perspectives in Drug Therapy of Older Adults
pp. 759
Opportunities in Drug Product Development in an Aging Population
Similar content
1,766
2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society
Authors:
Yousef Al-Saleh
,
Riad Sulimani
,
Shaun Sabico
…
Diagnostic performance of Radiological Society of North America structured reporting language for chest computed tomography findings in patients with COVID-19
Authors:
Halil Özer
,
Abidin Kılınçer
,
Emine Uysal
…
Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability
Authors:
George S. Stergiou
,
Ramakrishna Mukkamala
,
Alberto Avolio
…
See all similar
Cited by
1
Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization
Authors:
Rydvikha Govender
,
Susanna Abrahmsén-Alami
,
Anette Larsson
…
See all cited by